GRIFOLS | GRF

GRIFOLS traded at 9.15 this Thursday March 30th, increasing 0.26 or 2.88 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS gained 21.36 percent. Over the last 12 months, its price fell by 44.48 percent. Looking ahead, we forecast GRIFOLS to be priced at 8.44 by the end of this quarter and at 7.71 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
9.15
Daily Change
2.88%
Yearly
-44.48%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Alcon AG 64.94 2.92 4.71% -11.89%
Almirall SA 8.45 0.01 0.12% -26.71%
Amarin 1.54 0 0% -53.19%
Amadeus IT 60.66 1.74 2.95% 2.50%
argenx SE 341.90 -2.80 -0.81% 21.03%
Artemis Alpha 313.00 6.00 1.95% -9.28%
AstraZeneca 11,166.00 0 0% 10.21%
Bayer 57.78 0.51 0.89% -6.96%
Cie Automotive 26.30 0.58 2.26% 27.30%
Essilor 163.85 3.60 2.25% -1.47%
Ence Energia y Celulosa SA 3.38 0.03 0.78% 5.82%
Ferrovial 26.92 -0.02 -0.07% 11.56%
Fresenius Medical Care 38.86 0.72 1.89% -36.04%
Fresenius 24.40 0.25 1.04% -26.83%
Genmab 2,572.00 -22.00 -0.85% 4.34%
Galapagos 34.51 0.02 0.06% -38.70%
GRIFOLS 9.15 0.26 2.88% -44.48%
GlaxoSmithKline 1,420.00 -0.60 -0.04% -13.79%
Hikma Pharmaceutical 1,680.50 35.50 2.16% -18.46%
Inditex 30.34 0.59 1.98% 53.39%
Merck 171.75 2.55 1.51% -9.53%
Novartis 83.35 0.35 0.42% 2.58%
Philips 16.45 0.92 5.90% -40.68%
Roche Holding 260.65 1.80 0.70% -28.87%
Sanofi 99.43 -1.57 -1.55% 7.48%
Smith & Nephew PLC 1,102.50 -18.00 -1.61% -9.63%
UCB 83.50 0.58 0.70% -23.01%
Viscofan 67.20 -0.70 -1.03% 24.91%
William Demant Holding 245.20 5.20 2.17% -19.87%

Indexes Price Day Year
ES35 9207 136.40 1.50% 9.02%

GRIFOLS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Financials
Employees